215 related articles for article (PubMed ID: 28590015)
1. Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases.
Samaratunga H; Delahunt B; Srigley JR; Yaxley J; Johannsen S; Coughlin G; Gianduzzo T; Kua B; Patterson I; Nacey JN; Egevad L
Histopathology; 2017 Oct; 71(4):641-647. PubMed ID: 28590015
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.
Osunkoya AO; Nielsen ME; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men.
Samaratunga H; Delahunt B; Yaxley J; Perry-Keene J; Lamb DS; Srigley JR; Egevad L; Nacey JN
Pathology; 2014 Jan; 46(1):11-4. PubMed ID: 24300729
[TBL] [Abstract][Full Text] [Related]
4. Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy.
Kryvenko ON; Iakymenko OA; De Lima Guido LP; Bhattu AS; Merhe A; Mouzannar A; Briski LM; Oymagil I; Lugo I; Nemov I; Ritch CR; Kava BR; Punnen S; Jorda M; Parekh DJ; Gonzalgo ML
Arch Pathol Lab Med; 2022 Aug; 146(8):1012-1017. PubMed ID: 34739539
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.
Yaxley W; Delahunt B; Yaxley J; Thunders MC; Kenwright DN; Egevad L; Samaratunga H
Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972
[TBL] [Abstract][Full Text] [Related]
6. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
Amin A; Epstein JI
Am J Surg Pathol; 2011 Apr; 35(4):615-9. PubMed ID: 21383610
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
8. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
[TBL] [Abstract][Full Text] [Related]
12. Mucinous and secondary tumors of the prostate.
Osunkoya AO
Mod Pathol; 2018 Jan; 31(S1):S80-S95. PubMed ID: 29297488
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy.
Franklin A; Delahunt B; Egevad L; Yaxley J; Johannsen S; Gianduzzo T; Ganter J; Pecoraro C; Thunders M; Samaratunga H
Pathology; 2021 Feb; 53(2):199-204. PubMed ID: 33386122
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
15. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
[TBL] [Abstract][Full Text] [Related]
16. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.
Kryvenko ON; Gupta NS; Virani N; Schultz D; Gomez J; Amin A; Lane Z; Epstein JI
Arch Pathol Lab Med; 2013 May; 137(5):610-7. PubMed ID: 23627451
[TBL] [Abstract][Full Text] [Related]
17. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
Au S; Villamil CF; Alaghehbandan R; Wang G
Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS
J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
20. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
